A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.

Hans C LeeLei FengOnyeka OriabureVivian GrahamWendy ChenMaria BadilloRebecca LuHun J LeePreetesh JainElisabet E ManasanchRobert Z OrlowskiMichael L Wang

Published in: American journal of hematology (2021)

Keyphrases

multiple myeloma
phase iii
study protocol
phase ii
high dose
low dose
clinical trial
acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma
diffuse large b cell lymphoma